We showed that the NA of H9N2 was responsible for the high replication rates of Egyptian H9N2 viruses.
We generated a reassortant vaccine strain incorporating the HA from H5N1 and NA from H9N2 on a PR8 backbone.
The H5N2 vaccine was efficacious under laboratory and field conditions.